Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $485.9050 (-0.62%) ($485.9050 - $485.9050) on Thu. Apr. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.52% (three month average) | RSI | 59 | Latest Price | $485.9050(-0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) DIA(36%) SPLV(36%) IWD(35%) | Factors Impacting REGN price | REGN will decline at least -0.76% in a week (0% probabilities). VIXM(-20%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.76% (StdDev 1.52%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $488.36 | 5 Day Moving Average | $491.34(-1.11%) | 10 Day Moving Average | $495.56(-1.95%) | 20 Day Moving Average | $488.36(-0.5%) | To recent high | -4.3% | To recent low | 8.8% | Market Cap | $51.52b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |